About the Targeted Therapies In Cancer Session
Targeted therapies in cancer represent a revolutionary approach in cancer treatment, aiming to specifically target cancer cells while minimizing damage to healthy tissues. These therapies work by exploiting unique features or vulnerabilities present in cancer cells, such as specific mutations or overexpressed proteins. Unlike traditional chemotherapy, which can affect all rapidly dividing cells in the body, targeted therapies offer the potential for more precise and effective treatment with fewer side effects. Examples include monoclonal antibodies that block cancer-promoting signals and small molecule inhibitors that interfere with abnormal cellular processes. Research continues to identify new targets and develop innovative targeted therapies, offering hope for more personalized and efficient cancer treatments that improve patient outcomes and quality of life.
Topics Covered in Targeted Therapies In Cancer
Tyrosine Kinase Inhibitors
Monoclonal Antibodies
Actionable Mutations
Biomarker Testing
Acquired Resistance
Rational Combinations
Related Scientific Sessions at CIOC 2027
Why Attend the Targeted Therapies In Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Targeted Therapies In Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Targeted Therapies In Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Targeted Therapies In Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Targeted Therapies In Cancer Conference 2027 — FAQs
What is the Targeted Therapies In Cancer track at CIOC 2027?
The Targeted Therapies In Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Targeted Therapies In Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Targeted Therapies In Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Targeted Therapies In Cancer are all welcome — whether presenting or attending.
Can I present my research in the Targeted Therapies In Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Targeted Therapies In Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Targeted Therapies In Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.